West Pharmaceutical Services Inc
NYSE:WST

Watchlist Manager
West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc
NYSE:WST
Watchlist
Price: 322.335 USD 0.93%
Market Cap: 23.3B USD
Have any thoughts about
West Pharmaceutical Services Inc?
Write Note

West Pharmaceutical Services Inc
Non-Reccuring Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

West Pharmaceutical Services Inc
Non-Reccuring Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Non-Reccuring Items CAGR 3Y CAGR 5Y CAGR 10Y
West Pharmaceutical Services Inc
NYSE:WST
Non-Reccuring Items
-$100k
CAGR 3-Years
71%
CAGR 5-Years
57%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Non-Reccuring Items
-$231m
CAGR 3-Years
-9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Danaher Corp
NYSE:DHR
Non-Reccuring Items
-$222m
CAGR 3-Years
-114%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mettler-Toledo International Inc
NYSE:MTD
Non-Reccuring Items
-$30.7m
CAGR 3-Years
-52%
CAGR 5-Years
N/A
CAGR 10-Years
-11%
Agilent Technologies Inc
NYSE:A
Non-Reccuring Items
-$74m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
IQVIA Holdings Inc
NYSE:IQV
Non-Reccuring Items
-$94m
CAGR 3-Years
-30%
CAGR 5-Years
-6%
CAGR 10-Years
-26%
No Stocks Found

West Pharmaceutical Services Inc
Glance View

Market Cap
23.4B USD
Industry
Life Sciences Tools & Services
Economic Moat
Narrow

West Pharmaceutical Services Inc. is a leading global manufacturer of advanced drug delivery systems and medical device components, catering primarily to the pharmaceutical and biotechnology sectors. Founded in 1923, the company has built a robust reputation for its innovative solutions that enhance the safety and efficacy of medications. With a focus on producing high-quality packaging and delivery systems, West’s product lineup includes prefillable syringes, stoppers, and highly specialized devices that contribute to the growing demand for biologics and complex medications. This focus on quality has positioned West as a trusted partner for major pharmaceutical companies, and its strategic global footprint allows it to meet the rising demands of health systems worldwide. As the healthcare landscape evolves, West Pharmaceutical Services stands to benefit from several key industry trends, including the increased emphasis on patient-centric therapies and the demand for reliable and efficient drug administration methods. Investors can find assurance in the company’s commitment to innovation, as it invests heavily in research and development to stay ahead of emerging trends and regulatory changes. Additionally, West’s consistent financial performance, with steady revenue growth and healthy profit margins, showcases its resilience and operational efficiency. As the biopharmaceutical market continues to expand, West’s strategic alignment with cutting-edge therapeutic developments positions it well for future growth, painting a promising picture for potential investors looking to tap into the burgeoning healthcare sector.

WST Intrinsic Value
217.107 USD
Overvaluation 33%
Intrinsic Value
Price

See Also

What is West Pharmaceutical Services Inc's Non-Reccuring Items?
Non-Reccuring Items
-100k USD

Based on the financial report for Sep 30, 2024, West Pharmaceutical Services Inc's Non-Reccuring Items amounts to -100k USD.

What is West Pharmaceutical Services Inc's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 5Y
57%

Over the last year, the Non-Reccuring Items growth was 100%. The average annual Non-Reccuring Items growth rates for West Pharmaceutical Services Inc have been 71% over the past three years , 57% over the past five years .

Back to Top